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ABSTRACT
Characterization of Secondhand Smoke (SHS) and Materno-Fetal
Interactions in Receptors for Advanced Glycation
End-Products (RAGE)-Targeted Mice
Duane Ray Winden
Department of Physiology and Developmental Biology, BYU
Doctor of Philosophy
Receptors for advanced glycation end-products (RAGE) are pattern recognition receptors
of the immunoglobulin superfamily highly expressed in the lung. Likely functions include the
modulation of pulmonary inflammation during disease. However, the contributions of RAGE in
the developing lung in cases where secondhand smoke (SHS) exposure occurs are unknown. In
order to test the hypothesis that RAGE misexpression adversely affects lung morphogenesis, we
exposed gestating dams to a controlled dose of SHS during the last four critical days of in utero
lung morphogenesis. We discovered that both maternal and fetal lungs respond to SHS by upregulating RAGE. Exposed fetuses were markedly smaller compared to controls and lungs were
compromised in terms of apoptotic status, collagen abundance necessary in the derivation of
respiratory compartments, and the expression of MMP-9, a protease known to target extracellular
matrix. Interestingly, RAGE knock out animals similarly exposed to SHS were protected, in
part, from the same SHS-mediated pulmonary abnormalities. We next generated a conditional
transgenic mouse that provided an opportunity to genetically augment distal lung RAGE
expression in the absence of SHS exposure. Our RAGE transgenic mice (RAGE TG) were
severely hypoplastic and ultrastructural analysis demonstrated weakened basement membranes
in RAGE TG animals compared to controls. Specific observations in RAGE TG mice included
diminished type IV collagen required for basement membrane derivation, augmented MMP-9
expression, and inhibition of pulmonary vasculature visualized by Pecam-1 staining, a marker of
vascular endothelial cells. The further observation that FoxM1, a critical transcriptional
regulator of endothelial cell differentiation, was inhibited in RAGE TG mice suggested a novel
potential mechanism of impaired vascularization mediated by RAGE. These data provide
evidence that RAGE expression must be tightly regulated during lung organogenesis.
Furthermore, additional research into the nuances of RAGE signaling during development may
shed needed light on the pathobiochemistry of adult lung diseases that potentially have in utero
origins.
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CHAPTER 1: Introduction

Lung Development
The vertebrate lung is generated via complex branching programs and the derivation of
specialized cell types programmed by tissue specific transcription factors (Maeda, Davé, &
Whitsett, 2007). The initial budding of the mouse lung commences near embryonic day (E) 9-9.5
as the endoderm experiences a ventral diverticulum into the surrounding splanchnic mesoderm
under the control of thyroid transcription factor-1 (TTF-1) signaling (Maeda et al., 2007), (Serls,
Doherty, Parvatiyar, Wells, & Deutsch, 2005). The primordial lung buds branch to form the
primary tubules that will dictate proximal conducting airway structures (Maeda et al., 2007).
Factors secreted from the splanchnic mesenchyme such as FGF10 direct proper growth and
branching of newly formed lung buds (Min et al., 1998) prior to extensive branching and
budding that form the bronchial and bronchiolar tubes during the pseudoglandular phase of lung
development (E11.5-E16). It is at this period that specialized cell subsets begin to emerge.
Alveologenesis progresses through the canalicular (E16.5 to E17.5) and saccular (E17.5 through
post natal (PN) 4) stages of lung development by way of dilations of the terminal acinar tubules.
Lastly, extensive mesenchymal thinning and angiogenesis occur at post natal day (PN) 4 until
PN20 in order to permit the most efficient gas exchange (Figure 1.1).
Critical aspects of pulmonary organogenesis are specific signaling pathways and
transcription factor expression patters that require precise regulation and fidelity. In addition to
Wnt and FGF signaling, sonic hedgehog (SHH), bone morphogenetic protein 4 (BMP4),
forkhead box (FOX) proteins and vascular endothelial growth factors (VEGFs) greatly influence
cell proliferation, migration and differentiation (Figure 1.2) (Bellusci, Furuta, et al., 1997;
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Bellusci, Grindley, Emoto, Itoh, & Hogan, 1997; Bellusci, Henderson, Winnier, Oikawa, &
Hogan, 1996; Schmidt, Yan, Yan, & Stern, 2001; Shiratori et al., 1996; Shu, Jiang, Lu, &
Morrisey, 2002; Warburton et al., 2000; Weaver, Dunn, & Hogan, 2000; Wert, Dey, Blair,
Kimura, & Whitsett, 2002). Significant alterations in lung formation occur as a result of pathway
and transcription factor misregulation (Maeda et al., 2007).
Receptor for Advanced Glycation End-Products (RAGE)
The receptor for advanced glycation end-products (RAGE) is a member of the
immunoglobin superfamily of cell surface receptors. The receptor contains a V-region-like
domain crucial for ligand binding and two C-region like domains, a single-pass hydrophobic
transmembrane domain and a short, 43 amino acid, highly charged cytoplasmic domain essential
for intracellular signaling (Figure 1.3) (Buckley & Ehrhardt, 2010; Warburton et al., 2005).
RAGE is a dynamic receptor capable of binding ligands of various types, being able to
distinguish tertiary structures (Morbini et al., 2006). RAGE was initially characterized and
named for its ability to bind to non-enzymatically glycoxidized macromolecules, advanced
glycation end-products (AGEs). However, RAGE also binds other molecules including proinflammatory cytokine-like mediators of the S100/calgranulin family (S100A12 and S100B),
amyloid β-fibrils, high mobility group box 1 (HMGB1), Mac-1 (Buckley & Ehrhardt, 2010;
Schmidt et al., 2001) and specific DNA and RNA structures (Sims, Rowe, Rietdijk, Herbst, &
Coyle, 2010).
Because RAGE binds a handful of ligands it is thus linked to several divergent signaling
pathways. These include PI3/Akt (Toure et al., 2008), RhoGTPases (Hudson et al., 2008),
Jak/STAT (J. Y. Kim et al., 2008), and Src family kinases (Reddy et al., 2006). Of notable
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interest are two pathways stimulated by RAGE activation that are in response to either damageassociated molecular patterns (DAMPs) via NFκB pathways (Bianchi, Giambanco, & Donato,
2010) or tobacco smoke induced pulmonary inflammation that utilizes the Ras pathway
(Reynolds, Kasteler, Schmitt, & Hoidal, 2011). Key DAMP molecules are those of the
S100/calgranulin family and HMGB1, both of which bind to RAGE and other receptors
including toll-like receptor 4 (TLR4) (Halayko & Ghavami, 2009; Sims et al., 2010). These
molecular ligands, normally secreted post apoptotic or necrotic events, can serve as trophic
factors in low concentrations or enhance the inflammatory/cell death response in high
concentrations. Downstream gene products produced through RAGE signaling have included
NFκB, Cox-2, IL-1β, and TNF-α (Bianchi et al., 2010). Because the RAGE gene contains NFκB
binding sites in its promoter (Li & Schmidt, 1997) and is regulated by Egr-1 in cases of tobacco
smoke-related disease (Reynolds, Cosio, & Hoidal, 2006), a possible auto-inflammatory loop
may be triggered suggesting RAGE involvement in chronic disease states.
RAGE Isoforms
In addition to the full length RAGE isoform, other variants exist as a byproduct of
variable mRNA splicing. These isoforms include dominant negative RAGE (dn-RAGE), a
membrane anchored splice variant of RAGE capable of ligand binding but lacking the
intracellular domain necessary for signal transduction. RAGE has also been shown to exist in a
soluble secreted form sRAGE. The sRAGE isoform yields the same V and C-regions of the full
length-RAGE but lacks both the hydrophobic transmembrane and the intracellular domains
(Buckley & Ehrhardt, 2010). The altered variants of RAGE are thought to bind and sequester
ligands without the consequences of activating signal transduction, thereby inhibiting
transcription of gene products proposed as inflammatory targets in various tissues.
3

Roles of RAGE in Development
RAGE has been detected in many cell types including endothelium, smooth muscle,
macrophages and epithelium, however it is most abundant in the lung (Brett et al., 1993) limiting
its expression to alveolar type (AT) II cells and to the basolateral membranes of ATI
differentiated cells (Schmidt et al., 2001). RAGE is normally observed at low levels in nonpulmonary adult tissues throughout the body and up-regulated in cases of injury and disease.
However, RAGE expression is found at high quantities during lung neonatal development and in
adult pulmonary tissue suggesting possible contributions to lung organogenesis and homeostasis.
Meneghini, Francese, Carraro, and Grilli (2010) showed an additional interesting embryonic role
for RAGE when RAGE ligands including HMGB1 and S100B functioned to promote
proliferation and neuronal differentiation upon binding and subsequent activation. Numerous
studies have also shown RAGE activation and downstream gene activation in tumor progression,
further suggesting ties to proliferation (Arumugam, Simeone, Schmidt, & Logsdon, 2004; V.
Kim, Rogers, & Criner, 2008; Taguchi et al., 2000). In addition to fostering proliferation, RAGE
has been shown to enhance adherence of epithelial cells to collagen coated surfaces and
dynamically influence cell spreading, critical behaviors required for the developing alveolus
wherein cuboidal ATII cells transition to become squamous ATI cell necessary for efficient gas
exchange (Demling et al., 2006). Despite a growing collection of evidence for embryonic
functions, there remains little support for actual roles of RAGE in murine lung development.
RAGE-Mediated Pathology
Aside from developmental aspects, RAGE has been linked to numerous pathological
states including diabetes (Bohlender, Franke, Stein, & Wolf, 2005), atherosclerosis, sepsis,
rheumatoid arthritis and Alzheimer’s disease (Sims et al., 2010). Concentrations of RAGE have
4

found to be up-regulated in the disease states of diabetes (Bohlender et al., 2005), lung fibrosis
(He et al., 2007), acute respiratory distress syndrome (ARDS) (Nakamura et al., 2011),
polycystic kidney disease (Park, Seo, & Park, 2010) and chronic obstructive pulmonary disease
(COPD) (Ferhani et al., 2010; Wu, Ma, Nicholson, & Black, 2011) among many others. Since its
identification in response to high AGE concentrations observed in diabetic states, numerous
studies have also shown a relationship between inflammation and RAGE (Morbini et al., 2006;
Sparvero et al., 2009). Specifically the receptor was found to up-regulate various proinflammatory cytokines including IL-6 (Schmidt et al., 1994) TNF-α (Yan et al., 1996), IL-1β
(Hofmann et al., 1999) MCP-1 (Reynolds, Kasteler, et al., 2011), IL-8 (Reynolds, Kasteler, et al.,
2011), INF-α (Ruan et al., 2010) and other molecules such as matrix metalloproteinase 9 (MMP9) (Zhang et al., 2011). RAGE has also been shown to promote endothelial progenitor cell
apoptosis through oxidant cell stress (Chen et al., 2010).
Destabilization of Respiratory Epithelium by RAGE Over-expression
Previous experiments performed in the Reynolds lab have shown that tobacco smoke
increases RAGE expression and the expression of many of its known ligands. We have also
demonstrated that transgenic up-regulation of RAGE in the adult lung recapitulates aspects of
COPD, a smoke-induced disease with significant healthcare impact (M. P. Stogsdill et al., 2013).
Specifically, RAGE transgenic mice have emphysema and elevated pro-inflammatory signaling.
Because our data show that RAGE upregulation is sufficient to induce smoke-related
abnormalities, I decided to assess the effects of RAGE abrogation in the context of maternal
transfer of smoke particulates to the developing conceptus. Preliminary hypotheses in relation to
RAGE inhibition in the developing lung include protection from abnormal branching
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morphogenesis, cellular differentiation delays, impaired angiogenesis, and remodeling stemming
from uncontrolled cellular destabilization and apoptosis.

6

Figures

Figure 1.1: Key Morphogenic Events in Human and Mouse Lung
The primitive endoderm evaginates into the splanchnic mesenchyme to form the initial lung bud
(A). Through reciprocal signaling between the splanchnic mesenchyme and newly formed lung
outgrowths, extensive elongation and branching occur, thereby forming the primary bronchi (B
and D). Further generational branching and cellular differentiation occur until well-structured
alveoli are present in the distal lung (E). Image regenerated from Warburton et al. (2000).
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Figure 1.2: Functional Integration of Key Growth Factor Signaling Pathways
The functional integration of key growth factor signaling pathways in lung bud outgrowth, bud
arrest, and bud branching is shown. Panel A depicts the function of FGF10 in stimulating bud
outgrowth. Panel B depicts the function of BMP4 in stimulating lung branch tip outgrowth
together with FGF10. Panel C depicts the functional interaction of SHH and Hip with FGF10.
Panel D superimposes the functional integration of Fgf10, Bmp4, and Shh to mediate the delicate
balance between chemotaxis and proliferation leading to bud induction versus inhibition of bud
outgrowth. Panel E depicts the events that may determine interbranch length by leading to arrest
of bud outgrowth. FGF10 induces SPRY2, which in turn inhibits epithelial outgrowth. Panel F
depicts a potential mechanism for bud tip splitting in which WNT signaling drives Fibronectin
(FN) deposition between the branch tips, leading to epithelial cleft formation. Image adapted
Warburton et al. (2005).
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Figure 1.3: Structure of RAGE
A cartoon image showing full-length, dominant negative (DN-RAGE) and esRAGE, with
highlighted extracellular (V, C1 and C2), transmembrane and cytoplasmic domains of RAGE
(A). The surface representation model of RAGE is depicted (B). The blue, white and red image
shows the charge distribution of amino acids within the ectodomain of RAGE. Blue areas
represent localized positive charge, whereas red areas represent negatively charged regions.
Image regenerated from Fritz (2011).
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Abstract
Background: Receptors for advanced glycation end-products (RAGE) are immunoglobulin-like
pattern recognition receptors abundantly localized to lung epithelium. Our research demonstrated
that primary tobacco smoke exposure increases RAGE expression and that RAGE in part
mediates pro-inflammatory signaling during exposure. However, the degree to which RAGE
influences developing lungs when gestating mice are exposed to secondhand smoke (SHS) has
not been determined to date.
Methods: Timed pregnant RAGE null and wild type control mice were exposed to 4 consecutive
days of SHS from embryonic day (E)14.5 through E18.5 using a state of the art nose-only smoke
exposure system (Scireq, Montreal, Canada). RAGE expression was assessed using
immunofluorescence, immunoblotting, and quantitative RT-PCR. TUNEL immunostaining was
performed to evaluate effects on cell turnover. Matrix abnormalities were discerned by
quantifying collagen IV and MMP-9, a matrix metalloprotease capable of degrading basement
membranes.
Results: Pulmonary RAGE expression was elevated in both dams exposed to SHS and in fetuses
gestating within mothers exposed to SHS. Fetal weight, a measure of organismal health, was
decreased in SHS-exposed pups, but unchanged in SHS-exposed RAGE null mice. TUNEL
assessments suggested a shift toward pulmonary cell apoptosis. Matrix in SHS-exposed pups
was diminished as revealed by diminished collagen IV and increased MMP-9 expression.
Conclusions: RAGE augmentation in developing pups exposed to maternal SHS weakens
basement membranes and compromises pulmonary integrity.

Key words: RAGE, tobacco, lung, collagen
Running Title: Maternal smoke exposure compromises the developing fetal lung
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Introduction
Lung development involves precisely programmed events wherein communication
between endoderm and the surrounding mesoderm coordinates cell commitment and
differentiation (Ten Have-Opbroek, 1991). As development concludes, a vast surface area of
respiratory epithelium is positioned opposite a dynamic basement membrane through which
gases pass to and from a considerable vascular network. An environment conducive to the
appropriate spatial and temporal expression of target genes makes the coordination of specific
gene programs possible. Such programs result in the deposition of respiratory tissues critically
necessary for terrestrial life.
The receptor for advanced glycation end products (RAGE) is a cell-surface membrane
protein of the immunoglobulin superfamily composed of three domains: an extracellular ligand
binding domain, a domain necessary for membrane docking, and a cytosolic domain essential in
the perpetuation of intracellular signaling events (Buckley & Ehrhardt, 2010). RAGE is
expressed in several organs, but basal expression is primarily observed in the lung (Reynolds et
al., 2008). In fact, most other organs known to highly express RAGE and its signaling
intermediates are those in a diseased state (Ott et al., 2014). While its role in development is less
understood, RAGE may function in discrete ways during the programming of squamous
epithelium that must spread and appropriately adhere to matrix substrates (Demling et al., 2006).
For example, RAGE is identified to the baso-lateral membrane of alveolar epithelial cells and
localization in this domain enhances the binding of these epithelial cells to collagen in the matrix
(Demling et al., 2006). Combined with its role in the establishment of organ architecture, RAGE
may also influence organogenesis via its involvement in apoptotic pathways intricately
associated with defining cell populations in the mature alveolus (J. A. Stogsdill et al., 2012).
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While RAGE expression during lung organogenesis may assist in defining the respiratory
compartment, its participation in lung inflammatory signaling may further explain developmental
abnormalities. RAGE binds advanced glycation end-products (AGEs) during the orchestration
of inflammation and AGEs are commonly detected in tobacco smoke (Yamagishi, Matsui, &
Nakamura, 2008); however, the impact of elevated receptor availability during embryogenesis
has not been clearly tested. Additional RAGE ligands including cytokine-like mediators of the
S100/calgranulin family and high mobility group box 1 (HMGB-1) (Buckley & Ehrhardt, 2010;
Taguchi et al., 2000) further implicate downstream signaling pathways potentially involved in
mechanisms of abnormal lung derivation. Examples of deleterious effectors to cell turnover and
differentiation include Ras and NF-kB (Bianchi et al., 2010; Reynolds, Kasteler, et al., 2011),
two factors we’ve discovered to be RAGE targets. Because these signaling molecules increase
in cases of elevated apoptosis and matrix resorption, RAGE may initiate a signaling axis wherein
embryonic tissue loss and irreversible parenchymal remodeling occur.
Tobacco smoking and exposure to secondhand smoke (SHS) are widely accepted to be
causative factors for childhood asthma and chronic obstructive pulmonary disease (COPD)
affecting nearly 3 billion people worldwide (Rycroft, Heyes, Lanza, & Becker, 2012). Seminal
research by Tager et al. initially showed that SHS affected fetal lung development in a landmark
study of the effects of smoke exposure on neonatal pulmonary function (Tager et al., 1993).
Subsequent reasoning led to the concept that antenatal factors could affect normal lung
development and that chronic diseases have their origins in utero. Short and long term effects of
fetal exposure to maternal smoking during gestation results in hypoplastic lungs with fewer air
saccules coincident with bronchopulmonary dysplasia (BPD) persistently reduced pulmonary
function, and increased incidence and lifelong pulmonary disease. In fact, significant suppression
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of alveolarization in severe cases of SHS exposure causes neonatal lethality. It is important to
emphasize that the main effects of in utero SHS exposure on lung growth and differentiation are
likely the result of specific alterations in late stages of fetal lung development.
In the current study, the expression dynamics of RAGE was evaluated in the context of
SHS exposure and RAGE availability. The current research suggests that RAGE signaling
causes deterioration of the alveolar basement membrane through MMP-9 mediated collagen IV
destruction, and that RAGE-mediated inflammation observed during SHS exposure may
influence the trajectory of pulmonary morphogenesis.
Methods
Animals and SHS Exposure
All mice were in a C57Bl/6 background. Time mated mice were obtained and embryonic
(E) day 0 was noted as the day a vaginal plug was discovered. Pregnant mice were exposed to
secondhand smoke (SHS) commencing on E14.5 and the fourth consecutive day of SHS was
E17.5. Dams were then sacrificed on E18.5, pups were weighed, and lungs were resected for
histology, or molecular characterization. Mice were housed in a conventional animal facility
supplied with pelleted food and water ad libitum and maintained on a 12-hour light–dark cycle.
During exposure, mice were placed in soft restraints and connected to the exposure tower.
Animals were exposed to SHS generated by six standard research cigarettes (2R1, University of
Kentucky, Lexington, KY) through their noses using a nose-only exposure system (InExpose
System, Scireq, Canada). A computer-controlled puff was generated every minute and mice were
exposed to 10 minutes of secondhand smoke with a ten minute room-air exposure. This was
repeated three times. The SHS-exposed group inhaled SHS from six consecutive cigarettes per
day for four days. The SHS challenge chosen in the present study was associated with a good
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tolerance of mice to the SHS sessions, and an acceptable level of particulate density
concentration according to literature (Rinaldi et al., 2012; Vlahos et al., 2010). Control animals
were restrained similarly and were exposed to filtered room air for the same duration. Animal
use was in accordance with IACUC protocols approved by Brigham Young University.
Lung Morphology and Immunohistochemistry
Lungs were fixed in 4% paraformaldehyde, embedded in paraffin, and 5 µm sections
were obtained. Sections were dehydrated, deparaffinized, and antigen retrieval was performed
using the citrate buffer method (Reynolds, Mucenski, Le Cras, Nichols, & Whitsett, 2004;
Reynolds, Mucenski, & Whitsett, 2003). RAGE immunofluorescence was completed using goat
polyclonal IgG (AF1145, 1:500, R&D Systems, Minneapolis, MN). Sections were blocked in
5% donkey serum in PBS for 2 hours at room temperature, followed by incubation with primary
antibodies at 4°C overnight. Control sections were incubated in blocking serum alone. After
overnight incubation, all sections (including the controls) were washed using PBS/triton prior to
the application of Alexa Fluor® 488 Rabbit Anti-Goat IgG (Invitrogen, Carlsbad, CA) secondary
antibodies for 1 hour at room temperature. For immunohistochemistry, slides were blocked,
incubated with primary and appropriate secondary antibodies that utilize HRP conjugation with
the Vector Elite Kit (Vector Laboratories; Burlingame, CA). Antibodies for collagen IV (1:500,
Abcam, Cambridge, MA, ab6586), and MMP-9 (1:200, Santa Cruz Biotechnology, Santa Cruz,
CA, sc-6840) were used in the experiments. No staining was observed in sections without
primary or secondary antibody.
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Immunoblotting
Lungs from E18.5 mouse embryos were homogenized in RIPA buffer with protease
inhibitors (Thermo Fisher). BCA quantification was performed to ensure equal sample loading
(Thermo Fisher). Immunoblotting was performed using antibodies against RAGE (AF1145),
collagen IV (Abcam, 1:5,000, ab6586) and MMP-9 (Santa Cruz, 1:500, sc-6840) using standard
protocols discussed in previous work (Reynolds, Kasteler, et al., 2011; Reynolds, Schmitt, et al.,
2010). Goat anti-rabbit (Vector Labs, Burlingame, CA, PI-1000 secondary antibody
concentration was 1:10,000 for collagen IV and 1:5,000 for all other blots. Band densities were
assessed using UN-SCAN-IT software (Silk Scientific, Orem, UT).
qRT-PCR
Quantitative Real-Time PCR was performed using total RNA from lungs of E18.5 mice,
and was performed as previously described [15]. After isolation, total RNA was converted to
cDNA, and qRT-PCR was performed using primers specific for Rage (5′- ACT ACC GAG TCC
GAG TCT ACC -3’ and 5′- GTA GCT TCC CTC AGA CAC ACA -3′) and GAPDH (5'- TAT
GTC GTG GAG TCT ACT GGT -3' and 5'- GAG TTG TCA TAT TTC TCG TGG -3')
synthesized and HPLC purified by Invitrogen Life Technologies (Grand Island, NY).
Statistical Analysis
Results are presented as the means ± S.D. of six replicate pools per group. Means were
assessed by one and two-way analysis of variance (ANOVA). When ANOVA indicated
significant differences, student t tests were used with Bonferroni correction for multiple
comparisons. Results are representative and those with p values <0.05 were considered
significant.
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Results
Secondhand Smoke (SHS) Exposure During Embryogenesis Induces RAGE Expression
Pregnant dams were nasally exposed to SHS during the last four consecutive days of
gestation. Compared to basal pulmonary RAGE expression (Figure 2.1A), immunofluorescence
revealed that lungs in wild type pregnant dams respond to SHS exposure by increasing RAGE
expression (Figure 2.1B). Confirmatory experiments that utilized immunoblotting were aimed at
quantifying RAGE expression. Compared to room air exposed animals, lungs from pregnant
wild type mice exposed to SHS markedly increased RAGE protein expression (Figure 2.1E) and
densitometry of the bands suggested a significant increase (Figure 2.1F). RAGE expression was
not detected in RAGE null mice following room air exposure (Figure 2.1C) or exposure to SHS
(Figure 2.1D). Lastly, quantitative RT-PCR was performed using total RNA from whole lungs
in order to correlate protein and mRNA expression levels. A significant increase in RAGE
mRNA was observed in wild type animals exposed to SHS when compared to room air controls
(Figure 2.1G).
Immunofluorescence and immunoblotting for RAGE were next repeated using fetal
E18.5 lung samples obtained from pups derived from room air or SHS-exposed pregnant dams.
As was the case in pregnant dams, wild type pups experienced a notable increase in RAGE
localization following SHS (Figure 2.2B) when compared to room air controls (Figure 2.2A).
Immunoblotting (Figure 2.2E) and densitometry of the resulting bands (Figure 2.2F) further
confirmed a coordinated increase in RAGE expression as a product of SHS availability. Just as
was observed in adults, RAGE was not detected in tissues obtained from RAGE KO animals
(Figure 2.2C and D).
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RAGE Abrogation Protected Against SHS-induced Fetal Weight Loss and Lung Apoptosis
Fetal weights were obtained due to the observation that SHS exposure correlated with
smaller offspring. Average total fetal weights revealed that SHS-exposure of wild type dams
resulted in a significant decrease (Figure 2.3). Averages also revealed that RAGE KO mice
experienced no significant weight loss following SHS exposure when compared to room air
exposed counterparts (Figure 2.3). Because of an established link between RAGE and apoptosis
in the developing lung (M. P. Stogsdill et al., 2013), we next assessed apoptotic trends via
immunostaining for TdT-FragEL DNA Fragmentation (TUNEL), a commonly accepted marker
of cell death. Apoptosis was not detected in lungs from E18.5 mice whose mothers experienced
room air throughout gestation (Figure 2.4A). TUNEL labeling revealed sporadic cells actively
undergoing apoptosis in lungs obtained from SHS-exposed wild type mice (Figure 2.4B, arrows).
While RAGE KO mice also manifested apoptotic cells following SHS exposure (Figure 2.4C),
the frequency of TUNEL positive cells was detectibly diminished. Lastly, quantification of
proliferating cell nuclear antigen (PCNA) revealed no measurable differences in the proliferation
status of pulmonary cells, regardless of mouse background or SHS exposure (not shown).
RAGE Mediates Diminished Collagen and Elevated MMP-9 Following SHS Exposure
An immunohistochemical analysis of type IV collagen was completed on lungs from
pups obtained from room air and SHS-exposed dams. The relative abundance of type IV
collagen was sought due to it being a plentiful collagen subtype common in basement
membranes. Staining for type IV collagen revealed a qualitative decrease in lungs from wild
type mice exposed to SHS (Figure 2.5B) compared to room air exposed controls (Figure 2.5A).
Lungs from SHS-exposed RAGE KO mice also appeared to have diminished type IV collagen
abundance (Figure 2.5C). Quantification of total type IV collagen was obtained by
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immunoblotting and densitometry revealed that SHS exposure correlated with decreased
expression (Figure 2.5D and E). Interestingly, decreased type IV collagen synthesis following
SHS exposure was partially blunted in pups from RAGE KO animals (Figure 2.5D and E).
In order to mechanistically identify molecules that potentially function in the targeting of
collagen metabolism, an analysis of matrix metalloprotease 9 (MMP-9) was conducted. MMP-9
is a downstream effector of RAGE and it degrades a host of collagens, including type IV (Parks
& Shapiro, 2000; M. P. Stogsdill et al., 2013). Immunostaining for MMP-9 revealed a marked
increase in sporadic pulmonary cells obtained from E18.5 wild type pups following SHS (Figure
2.6B) when compared to room air exposed controls (Figure 2.6A). While MMP-9 positive cells
were also observed in lung sections from SHS-exposed RAGE KO mice (Figure 2.6C), their
frequency was reduced. Immunoblotting was next employed in order to quantitatively assess
MMP-9 expression in total lung homogenates. Blotting (Figure 2.6D) and densitometry (Figure
2.6E) suggested profound up-regulation of MMP-9 in SHS-exposed wild type mice. However,
the absence of RAGE, at least in part, protected SHS-exposed RAGE KO mice from the high
MMP-9 levels observed in SHS-exposed wild type mice (Figure 2.6D and E).

Discussion and Conclusions
Effects of SHS on RAGE Expression and Fetal Weight
The current investigation sought to simultaneously elucidate the expression profiles of
pulmonary RAGE in gestating dams and their developing fetuses following SHS exposure. To
our knowledge, this is the first study that seeks to delineate the biology of RAGE in the context
of SHS exposure. Nicotine and a host of other tobacco related entities are known to traverse the
placental barrier (Vaglenova, Birru, Pandiella, & Breese, 2004) and lungs of such exposed
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fetuses experience developmental anomalies including branching defects and cell differentiation
delays (Sekhon et al., 1999). Our discovery that dams and pups both induce higher RAGE
expression suggests potential RAGE-mediated coping mechanisms that clearly warrant future
exhaustive studies. Unequivocal support for deleterious inflammation mediated by tobacco
smoke-induced RAGE has been provided by our laboratory (P R Reynolds et al., 2006;
Reynolds, Kasteler, et al., 2011; Robinson, Johnson, Bennion, & Reynolds, 2012; Robinson,
Stogsdill, Lewis, Wood, & Reynolds, 2012). While the intent of the current publication was not
to delineate the inflammatory effects of RAGE signaling during SHS exposure or the specific
contributions of its participants, its augmentation alone necessitates concern. In fact, a higher
level of concern is potentially suggested by this and related work due to the fact that the dams in
the current study were exposed to SHS. Research performed by Seller and Bnait (1995) and
several others was conducted on the premise that dams were exposed to primary smoking and
second hand effects in pups included skeletal abnormalities and neural tube defects. Our research
indicates that in addition to primary smokers that are unable or unwilling to quit, even SHS
exposure of expecting adults is a concern for the developing fetus.
The observation that fetal weights were decreased following SHS exposure supports the
previous work using primary smoking by Esposito, Horn, Greene, and Pisano (2008). A highly
intriguing result of our studies was the effect RAGE inhibition had on SHS stimulation. Smaller
gestational and term weights are associated with a host of perinatal complications including renal
development and sensory processing (Gill, May-Benson, Teasdale, & Munsell, 2013; Zohdi et
al., 2012). Because RAGE knock out pups exposed to SHS were not smaller at term, further
inspection into potential mechanisms of protection would be highly informative. Such studies at
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minimum should consider RAGE effects on placentation, nutrition, and relationships to
maturation following early periods of organogenesis.
Effects of SHS and RAGE on Pulmonary Matrix Deposition
SHS-induced alterations in cell turnover, including instances of apoptosis, are
complicated by compromised extracellular matrix. Cells necessary for the normal physiology of
the lung such as endothelium, respiratory epithelium, and conducting airway epithelium require
spatial integrity stabilized by collagen and other matrix molecules. A significant determinant of
the architectural matrix between cells is type IV collagen synthesis and secretion (Akashi et al.,
2001; Timpl, 1989). In fact, the importance of type IV collagen as a stabilizing molecule is
confirmed in research centering on COPD (Atkinson & Senior, 2003) and other adult
inflammatory diseases (Ohbayashi & Shimokata, 2005). Our qualitative and quantitative data
revealing diminished type IV collagen identifies an important concept relating to SHS exposure.
First of all, extracellular matrixes are targeted by smoke exposure and secondarily, RAGE
expressed by epithelial cells plausibly functions to signal matrix secreting cells in the developing
lung.
RAGE-ligand interactions initiate signaling via the activation of signaling intermediates
prior to the activation of NF-κB (Robinson, Stogsdill, et al., 2012). The current research sought
to determine to what extent MMP-9, a matrix metalloprotease (MMP) secreted by fibroblasts,
alveolar macrophages, and epithelial cells, functions in SHS exposed pups. MMPs are
endopeptidases that can destroy components of the extracellular matrix and MMP-9 is an NF-κB
target (Soler-Cataluna et al., 2005) that specifically targets type IV collagen (Klein & Bischoff,
2011). Because of their destructive capabilities, MMPs are recognized as not only central
players in instances of disease, but effectors during remodeling events observed during
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development as well (Andrea Page-McCaw, Andrew J. Ewald, & Zena Werb, 2007). For
example, MMPs are also considered potent mediators of normal lung morphogenesis that assist
in the orchestration of definitive lung parenchyma (Buckley, Medina, Kasper, & Ehrhardt, 2011;
Sipes et al., 2011).
Notably, MMP-9 has been directly implicated in the progression of bronchopulmonary
dysplasia (BPD), a developmental lung anomaly characterized by inflammation, lack of alveolar
septation, and abnormal pulmonary vascular development (Coalson, 2006). Our work builds
upon these discoveries by identifying MMP-9 as a SHS target that likely effectuates end points
via RAGE-mediated pathways.
In summary, RAGE expression and matrix destabilization are probable byproducts of
pulmonary SHS exposure during embryogenesis. This study suggests that protection from
damaging SHS-induced effects such as fetal weight decreases, matrix abundance, and MMP
imbalances is possible when RAGE is inhibited. Despite notable advancements in SHS research
provided by the current research, additional work is necessary that focuses on RAGE signaling
during pulmonary branching morphogenesis and to what extent RAGE alone is capable of
inducing SHS related lung phenotypes.
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Figures

Figure 2.1: RAGE Expression in Adult Lung
Significant up-regulation of RAGE was observed by immunofluorescence using sections of adult
mouse lung from wild type dams (A and B) and age-matched RAGE KO animals (C and D).
Specifically, red RAGE immunofluorescence was increased in wild type lungs exposed to SHS
(B) compared to room air controls (A) and no expression was detected in RAGE KO animals
exposed to room air (C) or SHS (D). Images were at 100X original magnification.
Immunoblotting using 10 µg of total lung lysates revealed marked up-regulation of RAGE in
lungs exposed to SHS compared to room air controls (E). Densitometry of RAGE in the blots
revealed an approximate 100% increase in protein expression (F). Quantitative RT-PCR
revealed a significant up-regulation of RAGE mRNA.
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Figure 2.2: RAGE Expression in Fetal Lung
Significant up-regulation of RAGE was observed by immunofluorescence using sections of
E18.5 mouse lungs in pups from time mated pregnant wild type dams (A and B) and agematched RAGE KO animals (C and D). Specifically, red RAGE immunofluorescence was
increased in wild type lungs exposed to SHS (B) compared to room air controls (A) and no
expression was detected in RAGE KO animals exposed to room air (C) or SHS (D). Images
were at 100X original magnification. Immunoblotting using 10 µg of total E18.5 lung lysates
revealed marked up-regulation of RAGE in lungs exposed to SHS compared to room air controls
(E). Densitometry of RAGE in the blots revealed an approximate 100% increase in protein
expression (F).
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Figure 2.3: Fetal Weight Comparison between Room Air and SHS-exposed Pups
Pups from SHS exposed dams were noticeably smaller. Measurement revealed that SHSexposed wild type pups were significantly decreased compared to age-matched pups from dams
exposed to room air during gestation. SHS-exposed RAGE KO pups were not significantly
decreased when compared to age-matched RAGE KO pups exposed to room air. *Statistical
difference (P ≤ 0.05) with at least three replicates per group.
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Figure 2.4: TUNEL Staining Showing Active Apoptosis
A detectable increase in the number of actively apoptosing cells by TUNEL staining was
observed in wild type pups exposed to SHS (arrows, B) when compared to room air controls (A).
There was no statistical difference in the occurrence of TUNEL-positive cells when room air
wild type pups (A) and RAGE KO pups (not shown) were compared. Apoptotic cells were
observed in RAGE KO pups exposed to SHS (C, arrow); however, the frequency was markedly
decreased.
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Figure 2.5: Collagen IV Changes Associated with Basement Membranes
Lungs from wild type pups exposed to room air (A) and SHS-exposed wild type (B) and RAGE
KO lungs (C) were stained for type IV collagen to qualitatively determine relative changes in
type IV collagen associated with basement membranes. Only subtly qualitative decreases in type
IV collagen were observed in SHS exposed animals. Immunoblotting for type IV collagen using
equal aliquots of 10 µg total lung protein revealed markedly decreased total type IV collagen
expression in SHS-exposed pups (D). Immunoblotting (D) and densitometry of the resulting
bands (E) demonstrated that SHS-induced decreases in type IV collagen expression in wild type
animals is more severe when compared to SHS-exposed RAGE KO mice.
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Figure 2.6: MMP-9 Increased Expression in SHS-exposed Pups
Lungs from wild type room air exposed (A) and SHS-exposed wild type (B) and RAKE KO
mice (C) were qualitatively immunostained for MMP-9. SHS induced a detectibly higher
number of MMP-9 positive cells (B, arrows) compared to SHS-exposed RAGE KO mice (C).
Immunoblotting for MMP-9 and related densitometry (E) using standardized aliquots of 10 µg
total lung protein revealed markedly increased MMP-9 expression in SHS-exposed wild type
animals and a detectible measure of protection in SHS-exposed RAGE KO animals.
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Abstract
Background: Receptors for advanced glycation end-products (RAGE) are cell surface receptors
prominently expressed by lung epithelium. Previous research demonstrated that over-expression
of RAGE by murine alveolar epithelial cells during embryogenesis caused severe lung
hypoplasia and neonatal lethality. However, the effects of RAGE over-expression on adjacent
matrix and endothelial cells remained unknown.
Methods: RAGE transgenic (TG) mice were generated that conditionally over-expressed RAGE
in alveolar type II cells when fed doxycycline (dox) from conception to E18.5. To evaluate
effects on the basement membrane, immunostaining and immunoblotting were performed for
collagen IV and MMP-9, a matrix metalloprotease capable of degrading basement membranes.
To assess changes in vasculature, immunostaining, immunoblotting and qRT-PCR were
performed for Pecam-1, a platelet endothelial cell adhesion marker also known as CD31. Lastly,
to characterize potential regulatory mechanisms of endothelial cell differentiation,
immunoblotting and qRT-PCR for FoxM1, a key endothelium-specific transcription factor of the
Forkhead Box (Fox) family, were completed.
Results: Qualitative immunostaining for collagen IV was less in RAGE TG mice compared to
controls and immunoblotting revealed decreased collagen IV in the RAGE TG mouse lung.
Additionally, elevated MMP-9 detected via immunostaining and immunoblotting implicated
MMP-9 as a possible downstream effector in matrix destabilization mediated by RAGE
signaling. Lastly, Pecam-1 assessment revealed a decrease in the prevalence of microvascular
endothelial cells coincident with FoxM1 abrogation in RAGE TG mice compared to controls.
Conclusions: RAGE over-expression by alveolar epithelium weakened the basement membrane
and associated matrix via increased MMP-9 activity. Furthermore, over-expression of RAGE
inhibited FoxM1, suggesting that anomalous transcriptional control contributes to decreased
endothelial cell prevalence in the TG mouse lung.

Keywords: RAGE, transgenic, endothelium, lung, collagen
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Introduction
Lung development results from reciprocal interactions between respiratory epithelium derived
from the foregut endoderm and the surrounding splanchnic mesenchyme. A sequential series of
developmental events leads to the formation of airways juxtaposed with vast capillary networks
necessary for efficient gas exchange in the neonate (Ten Have-Opbroek, 1991). Each of these
programmed events reveals that normal pulmonary morphogenesis depends on a very specific
program of temporal and spatial control of cellular differentiation, migration, and proliferation.
The receptor for advanced glycation end products (RAGE) is a cell-surface membrane
protein of the immunoglobulin superfamily composed of three domains: an extracellular ligand
binding domain, a domain necessary for membrane docking, and a cytosolic domain essential in
the perpetuation of intracellular signaling events (Buckley & Ehrhardt, 2010). RAGE is basally
expressed in diverse locations throughout the body and it is most abundantly expressed by lung
alveolar epithelium (Reynolds et al., 2008). While its role in development is less understood,
RAGE has been implicated in cell spreading and adherence (Demling et al., 2006). Demling et
al. specifically showed that RAGE is localized to the basolateral membrane of human alveolar
epithelial cells, and that increased expression of RAGE in these cells leads to increased binding
to collagen and a squamous cellular morphology (Demling et al., 2006). Another plausible role
for RAGE in development may involve its ability to control apoptosis that refines epithelial cell
quantity in definitive alveoli (J. A. Stogsdill et al., 2012).
While the precise control of RAGE expression during lung organogenesis likely assists in
controlling lung- specific genetic programs, its participation in lung inflammatory signaling in
the adult may explain developmental abnormalities when expression levels rise. RAGE is
already widely known to bind advanced glycation end- products (AGEs) during the orchestration
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of vascular inflammation related to hyperglycemia (Aronson, 2008); however, the impact of
elevated receptor availability on alveolar vasculature during embryogenesis has not been clearly
tested. In addition to AGEs, RAGE also binds cytokine-like mediators of the S100/calgranulin
family, high mobility group box 1 (HMGB-1) and amyloid β-fibrils (Buckley & Ehrhardt, 2010;
Taguchi et al., 2000). These ligands further implicate downstream signaling pathways potentially
involved in mechanisms of abnormal lung derivation. For example, S100s and HMGB-1 lead to
RAGE-mediated activation of Ras and NF-kB (Bianchi et al., 2010; Reynolds, Kasteler, et al.,
2011). Because these signaling molecules increase in cases of elevated apoptosis and matrix
resorption, RAGE may initiate a signaling axis wherein embryonic tissue loss and irreversible
parenchymal remodeling occur.
Previous research showed that a conditional transgenic (TG) mouse model that enhances
RAGE expression exhibited neonatal lethality due to severe pulmonary hypoplasia (Reynolds,
Stogsdill, Stogsdill, & Heimann, 2011). In the current study, the effect of RAGE over-expression
on the development of the alveolar basement membrane and adjacent vasculature were analyzed.
Electron microscopy of TG lungs identified notable separation of ATI cells from fragmented
basement membranes. The current research suggests that RAGE over-expression causes
deterioration of the alveolar basement membrane through MMP-9 mediated collagen IV
destruction, and that RAGE over-expression diminishes vascularization during organogenesis,
possibly via inhibition of FoxM1.
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Methods
Animals
All mice were in a C57Bl/6 background. RAGE Transgenic (TG) mice that overexpress
RAGE were created by mating SP-C-rtTA and TetO-RAGE single transgenic mice and transgene
expression was induced by feeding dams doxycycline (dox) from before conception until
sacrifice date at E18.5 (Reynolds, Stogsdill, et al., 2011). Animal use was in accordance with
IACUC protocols approved by Brigham Young University.
Lung Morphology and Immunohistochemistry
Lungs were fixed in 4% paraformaldehyde, embedded in paraffin, and 5 μm sections
were obtained. Standard H&E staining was performed and immunohistochemistry was
conducted using standard procedures previously elaborated (Reynolds, Allison, & Willnauer,
2010). Sections were dehydrated, deparaffinized, and antigen retrieval was performed using the
citrate buffer method (Reynolds et al., 2004; Reynolds et al., 2003). Slides were blocked,
incubated with primary and appropriate secondary antibodies that utilize HRP conjugation with
the Vector Elite Kit (Vector Laboratories; Burlingame, CA). Antibodies for the following were
used: Pecam-1 (1:500, BD Pharmingen, San Jose, CA, #553370), collagen IV (1:500, Abcam,
Cambridge, MA, ab6586), and MMP-9 (1:200, Santa Cruz Biotechnology, Santa Cruz, CA, sc6840). No staining was observed in sections without primary or secondary antibody. Picro-sirius
red staining was performed to assess general collagen (Direct Red 80, Sigma-Aldrich, Saint
Louis, MO, #365548).
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Electron Microscopy
Whole mouse lungs were excised and fixed overnight in a 2% glutaraldehyde/0.06 M
sodium cacodylate solution (pH 7.3), rinsed in sodium cacodylate and placed in 1% osmium
tetroxide/sodium cacodylate, then uranyl acetate overnight. Tissues were dehydrated in a graded
acetone series and embedded in Spurr’s resin. 80 nm sections were obtained using a RMC MT-X
Ultra Ultra-microtome (Tucson, AZ) and stained using Reynolds’ lead citrate. Sections were
photographed using a FEI Tecnai T12 electron microscope.
Immunoblotting
Lungs from E18.5 mouse embryos were homogenized in RIPA buffer with protease
inhibitors (Thermo Fisher). BCA quantification was performed to ensure equal sample loading
(Thermo Fisher). Immunoblotting was performed using antibodies against Pecam-1 (Santa Cruz,
1:1,000, sc-376764), FoxM1, (Santa Cruz, 1:1,000, sc-271746), collagen IV (Abcam, 1:5,000,
ab6586) and MMP-9 (Santa Cruz, 1:500, sc-6840) using standard protocols discussed in previous
work (Reynolds, Kasteler, et al., 2011; Reynolds, Schmitt, et al., 2010). Goat anti-rabbit (Vector
Labs, Burlingame, CA, PI-1000) secondary antibody concentration was 1:10,000 for collagen IV
and 1:5,000 for all other blots. Band densities were assessed using UN-SCAN-IT software (Silk
Scientific, Orem, UT).
qRT-PCR
Quantitative Real-Time PCR was performed using total RNA from lungs of E18.5 mice,
and was performed as previously described (Robinson, Johnson, et al., 2012). After isolation,
total RNA was converted to cDNA, and qRT-PCR was performed using primers specific for
Pecam-1 (5′-CTC CAA CAG AGC CAG CAG TA-3′ and 5′-GAC CAC TCC AAT GAC AAC
C A-3′), FoxM1 (5′-GCG ACT CTC GAG CAT GGA GAA TTG TCA CCT G-3′ and 5′-GCG
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CTA CTC GAG TTC GGT TTT GAT GGT-3′), and GAPDH (5′-CAG GGC TGC TTT TAA
CTC TGG-3′ and 5′-TGG GTG GAA TCA TAT TGG AAC A-3′) synthesized and HPLC
purified by Invitrogen Life Technologies (Grand Island, NY).
Statistical Analysis
Results are presented as the means ± S.D. of six replicate pools per group. Means were
assessed by one and two- way analysis of variance (ANOVA). When ANOVA indicated
significant differences, student t tests were used with Bonferroni correction for multiple
comparisons. Results are representative and those with p values <0.05 were considered
significant.
Results
Embryonic Up-regulation of RAGE Destabilizes the Respiratory Membrane
Traditional staining with hematoxylin and eosin revealed a striking phenotype wherein
the distal lung architecture in RAGE TG mice lacked sufficient parenchymal tissue (Figure 3.1A
and B). Isolated areas of distal lung development were sporadically observed; however, vacuous
regions that lacked matrix and associated cells were common. A closer inspection of RAGE TG
lung tissues by electron microscopy identified diminished, poorly fused basement membranes
that comprise the respiratory membrane (Figure 3.1C and D, arrows). Because of significant lung
tissue loss and only diffuse basement membranes in the lungs of E18.5 RAGE TG mice
following uninterrupted dox administration, our focus centered on basement membrane stability
in the context of RAGE up-regulation.
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Collagen is Diminished in RAGE Over-expressing Lungs
A general analysis of collagen was completed using a picro-sirius red stain, and the data
revealed little qualitative difference when RAGE TG mice and controls were compared (Figure
3.2A and B). Immunohistochemistry was subsequently performed for collagen IV, a prolific
collagen subtype common in basement membrane structure. Qualitatively, staining for collagen
IV revealed a discernible decrease in lungs from RAGE TG mice (Figure 3.2D) compared to
control lung sections (Figure 3.2C). In order to quantitatively assess collagen IV abundance,
immunoblotting using equal concentrations of lung homogenates was performed and collagen IV
was significantly diminished in RAGE TG lungs compared to controls (Figure 3.2E).
In order to decipher functional molecules in possible mechanisms of collagen
metabolism, an analysis of matrix metalloprotease 9 (MMP-9) was conducted. MMP-9 has
recently been identified as a molecule downstream of RAGE signaling in the lung (Parks &
Shapiro, 2000; M. P. Stogsdill et al., 2013). Immunostaining for MMP-9 revealed a marked
increase in cells from RAGE TG mouse lung that were actively synthesizing the protease (Figure
3.3A and B). While MMP-9 positive cells were observed in all lung sections, cell counts per high
powered field (HPF) revealed a significant increase in the lungs of RAGE TG mice compared to
controls (Figure 3.3C). In order to quantitatively assess MMP-9 expression in lung homogenates,
immunoblotting for MMP-9 was performed and band densities from RAGE TG mouse lungs
coincided with the significant elevation of MMP-9 positive cells (Figure 3.3D).
Foxm1 and Endothelial Cell Abundance is Decreased in RAGE Over-expressing Lungs
Because lungs from RAGE TG mice exposed to dox from conception to E18.5
experienced significant epithelial cell death (J. A. Stogsdill et al., 2012) and compromised
basement membrane stability, endothelial cell biology was also considered due to its proximity.
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It was hypothesized that abnormalities in alveolar epithelial cell turnover might occur in tandem
with the contraction of endothelial cells that share the same weakened basement membrane.
Immunostaining for Pecam-1, a common endothelial cell marker, revealed indistinguishable
differences when comparing RAGE TG and control lungs (Figure 3.4A and B). However,
quantitative real-time PCR using equal concentrations of mRNA from both groups revealed a
significant decrease in the expression of Pecam-1 mRNA in RAGE TG mice (Figure 3.4C). The
decrease in message was corroborated with immunoblotting for Pecam-1 in lung homogenates
wherein protein quantification was significantly decreased in the lungs of RAGE TG mice
compared to controls (Figure 3.4D).
Because transcription factors that orchestrate epithelial cell differentiation were already
known to be impaired in RAGE TG mice (Reynolds, Stogsdill, et al., 2011), an interest in
transcriptional regulation and the derivation of endothelial cells was cultivated. FoxM1 was
identified based on its effects on cell cycle progression in mesenchymal cells and because
FoxM1 null mice exhibit pulmonary microvascular abnormalities associated with diminished
Pecam-1 and vascular endothelial growth factor (VEGF) expression (I. M. Kim et al., 2005).
Real-time PCR analysis of FoxM1 revealed a nearly three-fold decrease in the expression of the
transcription factor in the lungs of RAGE TG mice compared to controls (Figure 3.5A).
Furthermore, when comparing control lung samples, immunoblotting identified a significant
decrease in the abundance of FoxM1 protein in RAGE TG lungs (Figure 3.5B).
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Discussion
Effects of RAGE Over-expression on Basement Membrane
The use of a conditional mouse model involving alveolar epithelium allowed for the
assessment of RAGE over- expression on the respiratory membrane that is comprised of alveolar
epithelium, endothelium, and a fused basement membrane. A sound respiratory membrane in
advanced organisms is critical to terrestrial life and accordingly, its strength and permeability
must be maintained. A significant determinant of the basement membrane’s interposition
between cells in the respiratory membrane is due to intricate collagen IV deposition (Nakano et
al., 2001; Timpl, 1989). In fact, the importance of collagen IV as a chief component of the bloodgas barrier is confirmed in research that identifies impaired basement membranes in clinical
conditions including COPD (Atkinson & Senior, 2003). Our qualitative and quantitative data
revealing diminished collagen IV identifies an intriguing paradigm in which increased
expression of pattern recognition receptors such as RAGE by epithelial cells can signal changes
in the surrounding matrix.
RAGE-ligand interactions initiate signaling via the activation of signaling intermediates
such as Ras, extra- cellular signal regulated kinase (ERK) 1/2, and c-Jun-NH2-terminal kinase
(JNK) 1/2 prior to nuclear translocation of active NF-κB (Robinson, Stogsdill, et al., 2012). The
current research sought to assess possible roles for MMP-9, a matrix metalloprotease (MMP)
secreted by fibroblasts, alveolar macrophages, and epithelial cells through pathways culminating
in NF-kB activation (Soler-Cataluna et al., 2005). MMPs comprise a family of 24 related
endopeptidases that degrade a variety of substrates, including components of the extracellular
matrix, and MMP-9 specifically targets collagen IV (Pardo & Selman, 2006). The destructive
functions of MMPs are critical in tissue remodeling observed in development and disease
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(Andrea Page-McCaw, Andrew J Ewald, & Zena Werb, 2007). Based on their multiple
biological activities, MMPs are considered participants in diverse pathological processes in the
lung (Rosas et al., 2008), but also as effectors during lung morphogenesis (Buckley et al., 2011;
Lee et al., 2011). Notably, MMP-9 has been directly implicated in the progression of
bronchopulmonary dysplasia (BPD), a developmental anomaly characterized by inflammation,
lack of alveolar septation, and abnormal pulmonary vascular development (Coalson, 2003). We
have shown that the over-expression of RAGE results in increased MMP-9 and decreased
collagen IV. As recently demonstrated in adult RAGE TG mice (M. P. Stogsdill et al., 2013), this
particular study confirms that MMP-9 is increased via a RAGE-mediated pathway during
development as well. While some additional studies in abdominal aortic aneurisms and HaCaT
keratinocytes describe MMP-9 induction via RAGE signaling, only in the current study was lung
development considered (Zhang et al., 2009; Zhu et al., 2012). Our new evidence points to
MMP-9-mediated remodeling in the developing lung under the control of RAGE signaling, a
particularly important concept given the abundance of RAGE in the lung.
Effects of RAGE Over-expression on Endothelium
Over-expression of RAGE by alveolar epithelial cells also directly influenced endothelial
cell behaviors in the lung. The lung mesenchyme undergoes vasculogenesis (de novo formation
of vessels) and angiogenesis (branching of new vessels from preexisting ones) in precisely
controlled pathways that require appropriate levels of VEGF and other regulatory molecules
(Breier, Albrecht, Sterrer, & Risau, 1992; Risau, 1997). We demonstrated that RAGE overexpression led to decreased development of pulmonary microvasculature associated with
diminished levels of Pecam-1 (I. M. Kim et al., 2005). Previous research revealed abnormal
thyroid transcription factor-1 (TTF-1) expression in the lung of perinatal RAGE TG mice
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(Reynolds, Stogsdill, et al., 2011). TTF-1 is a phosphorylated member of the Nkx2 family of
homeodomain-containing transcription factors and TTF-1 phosphorylation mutants have deficits
in lung vascularity due to decreased Pecam-1 and VEGF expression (DeFelice et al., 2003).
Figure 3.6 demonstrates significantly decreased TTF-1 expression in the lungs of RAGE TG
mice compared to controls during periods through E18.5. It is therefore likely that decreased
staining for Pecam-1 relates to misregulation of TTF-1 among other important factors.
A central feature likely involved in endothelial cell derivation and the coordination of
vessel formation in the RAGE TG mouse lung are the contributions of FoxM1. The Forkhead
Box (Fox) proteins consist of extensive transcription factors homologous with the Winged
Helix/Forkhead DNA binding factors (Clark, Halay, Lai, & Burley, 1993). Notably, Fox proteins
FoxA2, FoxJ1, FoxF1, and FoxP each play critical roles in transcriptionally regulating branching
morphogenesis and vasculogenesis in the developing lung (Brody, Yan, Wuerffel, Song, &
Shapiro, 2000; Kalin et al., 2008; Wan et al., 2004). In particular, deletion of FoxM1 is lethal
during the embryonic period and selective inhibition revealed it is important during pulmonary
development where it activates genes involved in G1/S and G2/M progression through its
interaction with Cdk-Cyclin complexes and p300/CBP co-activators (Costa, 2005). Pulmonary
microvascular abnormalities associated with diminished levels of Pecam-1, transforming growth
factor (TGF)-β receptor type II, ADAM-17, VEGF receptors, FLK-1, Aurora B kinase, LAMA4,
and the FoxF1 transcription factor were observed in lungs of FoxM1 null mice (I. M. Kim et al.,
2005). Conversely, conditional up-regulation of FoxM1 caused increased proliferation of
alveolar and bronchial epithelial cells, as well as smooth muscle and endothelial cells via the
activation of cell cycle promoting factors (Kalinichenko, Lim, Shin, & Costa, 2001). Because
RAGE TG mice express less FoxM1, and VEGF is a direct transcriptional target of FoxM1
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(Mirza et al., 2010), the data identify as a precursor to measurable lung destruction in smokers
(Gordon et al., 2011). Accordingly, in addition to disease progression observed in mature lungs,
this work further implicates RAGE signaling in pathways that regulate lung remodeling during
embryogenesis.
Conclusion
In summary, matrix destabilization and FoxM1-mediated effects on respiratory
membrane cells are probable determinants of the hypoplastic lung observed in perinatal RAGE
TG mice. Our prior research that revealed a fas ligand- mediated shift toward apoptosis in the
lung periphery (J. A. Stogsdill et al., 2012) and impaired ATII-ATI transition reveals that both
abnormal apoptosis and loss of repair mechanisms mediated by FoxM1 likely result in impaired
lung development. Even with these important advancements in the study of RAGE signaling
during lung morphogenesis, additional research is still required that centers on precise signaling
pathways involved in cell responses to RAGE up-regulation.
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Figures

Figure 3.1: Lung Histology and Ultrastructure in RAGE TG Mice Compared to Controls
Significant lung hypoplasia was observed in RAGE TG mice exposed to doxycycline from
conception to E18.5 (B) compared to lungs from control littermates (A). Images were at 100X
original magnification. Electron microscopy of RAGE TG and control mice fed doxycycline
from conception until sacrifice date at E18.5 revealed altered basement membrane (BM)
integrity in the alveolar compartment. Wild type BM was distinct and pronounced (C, arrow)
compared to RAGE TG BM that appeared diminished and fragmented (D, arrow). Magnification
for each image is 6,500X.
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Figure 3.2: Collagen Expression in RAGE TG Mice Compared to Controls
Lungs from Control (Co, A and C) and RAGE TG (B and D) mice were stained for Pico-Red (A
and B) to visualize total collagen content and type IV collagen (C and D) and only qualitative
decreases were observed. Images were at 100X original magnification. Immunoblotting for type
IV collagen using equal aliquots of 10 μg total lung protein revealed markedly decreased total
type IV collagen expression in RAGE TG mouse lungs compared to controls (E). *Statistical
difference (P ≤ 0.05) with at least three replicates per group.

52

Figure 3.3: MMP-9 Expression in RAGE TG Compared to Controls
Lungs from control (Co, A) and RAGE TG (B) mice were qualitatively immunostained for
MMP-9 and blinded counts of MMP-9 positive (+) cells were averaged per high powered field
(HPF, C). Images were at 100X original magnification. Immunoblotting for MMP-9 using
standardized aliquots of 10 μg total lung protein revealed markedly increased MMP-9 expression
in RAGE TG mouse lungs compared to controls (D). *Statistical difference (P ≤ 0.05) with at
least three replicates per group.
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Figure 3.4: Pecam-1 Expression in RAGE TG Compared to Controls
Lungs from control (Co, A) and RAGE TG (B) mice were qualitatively immunostained for
Pecam-1, revealing no appreciable differences. Images were at 100X original magnification.
Quantitative RT-PCR (C) and immunoblotting (D) for Pecam-1 using standardized aliquots of
total lung mRNA or protein revealed markedly decreased Pecam-1 expression in RAGE TG
mouse lung compared to controls. *Statistical difference (P ≤ 0.05) with at least three replicates
per group.
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Figure 3.5: FoxM1 Expression in RAGE TG Compared to Controls
Quantitative RT-PCR (A) and immunoblotting (B) for FoxM1 using standardized aliquots of
total lung mRNA or protein revealed markedly decreased FoxM1 expression in RAGE TG
mouse lung compared to controls (Co). *Statistical difference (P ≤ 0.05) with at least three
replicates per group.
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Figure 3.6: Lung Homogenates from E15.5-E18.5 RAGE TG Mice
RAGE TG mice and controls were immunoblotted for TTF-1 using a rabbit polyclonal antibody
(WRAB-76694, Seven Hills Bioreagents, Cincinnati, OH) at a dilution of 1:1000. B.
Densitometry of resulting bands were quantified as outlined in the Methods.
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CHAPTER 4: GENERAL DISCUSSION
The current investigation sought to simultaneously elucidate the expression profiles of
pulmonary RAGE in gestating dams and their developing fetuses following SHS exposure. To
our knowledge, this is the first study that seeks to delineate the biology of RAGE in the context
of SHS exposure. Our discovery that dams and pups both induce higher RAGE expression
suggests potential RAGE-mediated coping mechanisms that clearly warrant future exhaustive
studies. Unequivocal support for deleterious inflammation mediated by tobacco smoke-induced
RAGE has been provided by our laboratory (P R Reynolds et al., 2006; Reynolds, Kasteler, et
al., 2011; Robinson, Johnson, Bennion, & Reynolds, 2012; Robinson, Stogsdill, Lewis, Wood, &
Reynolds, 2012). Our research indicates that in addition to primary smokers that are unable or
unwilling to quit, even SHS exposure of expecting adults is a concern for the developing fetus.
The observation that fetal weights were decreased following SHS exposure supports the
previous work using primary smoking by Esposito, Horn, Greene, and Pisano (2008). A highly
intriguing result of our studies was the effect RAGE inhibition had on SHS stimulation. Such
studies at minimum should consider RAGE effects on placentation, nutrition, and relationships to
maturation following early periods of organogenesis.
SHS-induced alterations in cell turnover, including instances of apoptosis, are
complicated by compromised extracellular matrix. Cells necessary for the normal physiology of
the lung such as endothelium, respiratory epithelium, and conducting airway epithelium require
spatial integrity stabilized by collagen and other matrix molecules. A significant determinant of
the architectural matrix between cells is type IV collagen synthesis and secretion (Akashi et al.,
2001; Timpl, 1989). Our qualitative and quantitative data revealing diminished type collagen IV
identifies an important concept relating to SHS exposure. First of all, extracellular matrixes are
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targeted by smoke exposure and secondarily, RAGE expressed by epithelial cells plausibly
functions to signal matrix secreting cells in the developing lung. A significant determinant of the
basement membrane’s interposition between cells in the respiratory membrane is due to intricate
collagen IV deposition (Nakano et al., 2001; Timpl, 1989). Our qualitative and quantitative data
revealing diminished collagen IV identifies an intriguing paradigm in which increased
expression of pattern recognition receptors such as RAGE by epithelial cells can signal changes
in the surrounding matrix.
The current research sought to determine to what extent MMP-9, a matrix
metalloprotease (MMP) secreted by fibroblasts, alveolar macrophages, and epithelial cells,
functions in SHS exposed pups. Because of their destructive capabilities, MMPs are recognized
as not only central players in instances of disease, but effectors during remodeling events
observed during development as well (Andrea Page-McCaw, Andrew J. Ewald, & Zena Werb,
2007). Our work builds upon these discoveries by identifying MMP-9 as a SHS target that likely
effectuates end points via RAGE-mediated pathways. The current research sought to assess
possible roles for MMP-9, a matrix metalloprotease (MMP) secreted by fibroblasts, alveolar
macrophages, and epithelial cells through pathways culminating in NF-kB activation (SolerCataluna et al., 2005). MMPs comprise a family of 24 related endopeptidases that degrade a
variety of substrates, including components of the extracellular matrix, and MMP-9 specifically
targets collagen IV (Pardo & Selman, 2006). Based on their multiple biological activities, MMPs
are considered participants in diverse pathological processes in the lung (Rosas et al., 2008), but
also as effectors during lung morphogenesis (Buckley et al., 2011; Lee et al., 2011). We have
shown that the over-expression of RAGE results in increased MMP-9 and decreased collagen IV.
As recently demonstrated in adult RAGE TG mice (M. P. Stogsdill et al., 2013), this particular
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study confirms that MMP-9 is increased via a RAGE- mediated pathway during development as
well. Our new evidence points to MMP-9-mediated remodeling in the developing lung under the
control of RAGE signaling, a particularly important concept given the abundance of RAGE in
the lung.
We demonstrated that RAGE over-expression led to decreased development of
pulmonary microvasculature associated with diminished levels of Pecam-1 (I. M. Kim et al.,
2005). Previous research revealed abnormal thyroid transcription factor-1 (TTF-1) expression in
the lung of perinatal RAGE TG mice (Reynolds, Stogsdill, et al., 2011). TTF-1 is a
phosphorylated member of the Nkx2 family of homeodomain-containing transcription factors
and TTF-1 phosphorylation mutants have deficits in lung vascularity due to decreased Pecam-1
and VEGF expression (DeFelice et al., 2003). Figure 3.6 demonstrates significantly decreased
TTF-1 expression in the lungs of RAGE TG mice compared to controls during periods through
E18.5.
A central feature likely involved in endothelial cell derivation and the coordination of
vessel formation in the RAGE TG mouse lung are the contributions of FoxM1. Notably, Fox
proteins FoxA2, FoxJ1, FoxF1, and FoxP each play critical roles in transcriptionally regulating
branching morphogenesis and vasculogenesis in the developing lung (Brody et al., 2000; Kalin et
al., 2008; Wan et al., 2004). Conversely, conditional up-regulation of FoxM1 caused increased
proliferation of alveolar and bronchial epithelial cells, as well as smooth muscle and endothelial
cells via the activation of cell cycle promoting factors (Kalinichenko et al., 2001).
In summary, RAGE expression and matrix destabilization are probable byproducts of pulmonary
SHS exposure during embryogenesis. This study suggests that protection from damaging SHSinduced effects such as fetal weight decreases, matrix abundance, and MMP imbalances is
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possible when RAGE is inhibited. Despite notable advancements in SHS research provided by
the current research, additional work is necessary that focuses on RAGE signaling during
pulmonary branching morphogenesis and to what extent RAGE alone is capable of inducing
SHS related lung phenotypes.
Relevance of Research
This research will improve our knowledge of the contributions of RAGE during
pulmonary development, particularly as it participates in signaling stemming from SHS
exposure. The research is notable because it aims to demonstrate for the first time the role of
RAGE in developing lungs exposed to maternal SHS. RAGE has been linked to the spreading
and branching of lung parenchyma throughout organogenesis (Demling et al., 2006) as well as to
an increasing array of smoke related maladies. Because abnormal spreading and branching in
tobacco smoke environments may lead to embryonic complications resulting from branching
delays, this research may also provide insight into compromised lung function observed in the
offspring of smokers.
Disease progression observed in smoke-related pulmonary complications such as COPD
in the adult and lung hypoplasia in the neonate has been greatly debated. Numerous models have
surfaced for COPD and hypoplasia including the vicious cycle hypotheses, which involve
chronic inflammation and alveolar destabilization (Sethi, Mallia, & Johnston, 2009).
Consideration of these models naturally leads to various proposed therapeutic interventions.
Because RAGE has been shown to be upregulated in human lungs diagnosed with smoke-related
lung diseases (Ferhani et al., 2010), this research could also provide further evidence for its role
in pulmonary disease progression.
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2007 – Current
2006 – Current
2005 – Current
2005
2003 – Current
2002 – Current
2000 – 2003,
2007 – 2010
1993
1985 – 1987

Professional Experience
2011-Current
Roseman University of Health Sciences
South Jordan, Utah
Assistant Professor
Responsibilities: Taught course combining embryology, histology,
anatomy, physiology, and pathophysiology for dental students. This
course helps to prepare students for first year national board examinations.
Block director for eight courses. Coordinate adjunct faculty to teach
blocks. Serve on the admissions, nursing faculty search, ADEA abstract
review committee, by-laws committee, curriculum committee, and CODA
accreditation committee. Co-chair the NBDE Part 1 course review
committee. Serve on the Student Professionalism Board.
2011

Roseman University of Health Sciences
South Jordan, Utah
Educational Consultant
Responsibilities: Design curriculum for biomedical course combining
embryology, histology, anatomy, physiology, and pathophysiology for
dental students. This course helps to prepare students for first year national
board examinations.
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2005 – 2011

Ameritech College (American Institute of Medical and Dental
Technology) / Provo and Draper, Utah
Instructor
Responsibilities: Anatomy and Physiology, Clinical Mathematics,
Pharmacology, and Chemistry instructor, develop curriculum for nursing
and surgical technician courses to ensure students are prepared to pass
licensing exam, teach CPR and AED courses. Serve on the curriculum,
technology in the classroom, exam, and NLNAC accreditation
committees. Developed curriculum for and taught above courses as well as
lifespan development. Manage the online grade book for the nursing
department. Resolve in-house IT problems.

2008-2010

Mountainview Hospital
Payson, Utah
Registered Nurse
Responsibilities: Continuing Care nurse, assess, plan care of patients,
implement care standards, and evaluate progress of patients in the
continuing care and rehabilitation setting; Emergency room nurse, assess,
plan care of patients, implement care standards, and evaluate progress of
patients in the emergency setting.

2007

Ameritech College / Provo and Draper, Utah
Regional Director of Academic Affairs
Responsibilities: Assist Campus Directors and Campus Directors of
Education as a corporate resource in the development, implementation,
and the continuous improvement of the educational programs and
processes at the campus level, while functioning as a resource to and
providing guidance, assistance, and oversight to the Campus Academics
Department. To carry the vision and philosophy of Ameritech College to
all staff, students, faculty, and customers, as well as the public at large.

2006 – 2007

Ameritech College / Provo, Utah
Campus Director – Provo Campus
Responsibilities: Provide leadership to all faculty members, administrative
staff and students, maintaining a professional, caring demeanor at all
times. Plan, direct, organize and control all School campus operations with
the assistance of headquarters administrative staff. Monitor and control the
effectiveness of processes intended to meet the needs of students while
remaining in compliance with State, federal and accreditation guidelines.
Provide guidance to the School’s administrative staff on budgeting and
strategic planning issues. Approve student payment arrangements and sign
checks as required. Organize and supervise the day-to-day functions of
the Administration staff. Coordinate and facilitate communication and
information flow between the School’s departments and with the
administrative staff to ensure efficient operations. Maintain compliance
with federal and State regulations as well as ABHES and other accrediting
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bodies. Hire, train, supervise and evaluate staff as needed to maintain the
efficient operation of the School by retaining the most skilled employees
possible. Ensure that the School’s admissions, education and financial aid
programs meet operational objectives. Anatomy and Physiology
instructor, teach CPR and AED courses.
2005 – 2007

Ameritech College - American Institute of Medical and Dental
Technology/ Provo and Draper, Utah Campuses
Director of Education
Responsibilities: Coordinate all instruction for the college, access
compliance with accreditation standards, ensuring a high level of
instruction through classroom observation and student evaluation of
instructors, direct curriculum re-development for all programs, re-structure
all programs to fit into a modular format with general education core
classes, hold program director meetings, in-service instructors on
curriculum development and teaching methodologies, Anatomy and
Physiology instructor, teach CPR and AED courses.

2003 – 2004

Healthcare Career College – Academy of Nursing / Salt Lake City, Utah
Academic Dean
Responsibilities: Coordinate all instruction for the college, access
compliance with accreditation standards, hiring of faculty and instructors,
ensuring a high level of instruction through classroom observation and
student evaluation of instructors, coordinate the moving of course material
to the internet through the IT department with instructors and faculty,
course scheduling and resource allocation, curriculum committee chair.

2002 – 2003

Academy of Nursing / Salt Lake City, Utah
Science Department Chair
Responsibilities: Coordinate instruction of the science courses at the
Academy of Nursing, preparation of material for IT department for web.

2002

Academy of Nursing / Salt Lake City, Utah
Full-time Faculty
Responsibilities: Anatomy and Physiology instructor.

2002

Academy of Nursing / Salt Lake City, Utah
Part-time Instructor
Responsibilities: Anatomy and Physiology instructor.

1996 – 2011

Brigham Young University / Provo, Utah
Adjunct Faculty
Responsibilities: Anatomy instructor, Human Dissection instructor, develop
curriculum for courses.
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1997

Brigham Young University / Provo, Utah
Part-time Faculty
Responsibilities: Human Biology instructor, develop curriculum for course.

1988 – 1994, 2014

Brigham Young University / Provo, Utah
Teaching Assistant
Responsibilities: Lecture and laboratory teaching assistant for a variety of
courses including: anatomy, dissection, histology, embryology, physiology,
zoology.

1991 – 1994, 2014

Brigham Young University / Provo, Utah
Research Assistant
Responsibilities: Organize research staff and manage colonies of mice for
research, write SOPs and reports.

1994

University of Washington / Seattle, Washington
Research Assistant
Responsibilities: Write SOPs and reports for embryo cultures and DNA
testing.

Other Professional Experience
2000 – 2002
ClearCourse Inc. / Provo, Utah
Director, Project Engineering
Responsibilities: Help project managers to ensure that projects were
completed and on track and on budget, allocate resources to different
teams, find outside resources.
1998 – 2000

ClearCourse Inc. / Provo, Utah
Project Manager
Responsibilities: Manage teams of graphic artists, software developers and
software engineers to develop educational software.

1995 – 1998

Taras Development Corp. and William M. Bancroft / Provo, Utah
Graphic Designer
Responsibilities: Design interfaces for educational software. Knowledge of
Adobe Photoshop, Premiere, In Design and most Microsoft products.

1995

Taras Development Corp. / Provo, Utah
Educational Consultant
Responsibilities: Provide content for software training package in the field of
Teratology.
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Certification
• RN
• LPN
• BLS Instructor
• BLS
• ACLS
• EMT - Basic
Patents
Method and system for computerized authoring, learning, and evaluation
U.S. Patent Number 6,315,572
A method and system for computerizing authoring, learning, and evaluation is provided.
The computerized system comprises a central processing unit and related memory and
storage capacity to operate an authoring, learning, and evaluation system stored in a
computer program. The authoring, learning, and evaluation system comprises an
authoring portion and a presentation portion. Through the use of intuitive interface
elements, the authoring portion allows an author to quickly and easily construct a lesson
from a pool of relevant data. Data can be organized into objects or concepts that are
related to one another in a reasoned fashion so that coherent testing of the data, as
presented to a user, may be achieved.
Systems and methods for organizing data relationships
U.S. Patent Number 20,020,042,041
Systems and methods for creating and using a cognitive index, selectively providing
objects from the index, and organizing information to generate questions contextually
relevant to the information associated with the index. A computer device is used to create
a cognitive index that includes various objects and/or information that may be selectively
related. The index further includes one or more conceptual nodes that may be related to
one or more associated nodes through one or more expressions. Each associated node
may include objects and/or information relating thereto, which may be selectively and/or
automatically provided from the index. The objects and/or information associated with
the index may be used to provide information requested and/or to generate questions
contextually relevant to the information associated with the index.
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Research
Characterization of Secondhand Smoke (SHS) and Materno-Fetal Interactions in
Receptors for Advanced Glycation End-Products (RAGE)-Targeted Mice
The presence of Cytochrome p-450 1b1, a liver enzyme present between gestational days
9-12, in mice.
2,4 and 2,5 diaminotoluene as an agent for chemically induced birth defects, fetotoxicity and
carcinogenesis in mice.
Carbon black oil as an agent for chemically induced birth defects, fetotoxicity and
carcinogenesis in mice.
Research Publications
Peer-Reviewed Publications
Winden D.R., Ferguson N.T., Bukey B.R., Geyer A.J., Wright A.J., Jergensen
Z.R., Robinson A.B., Stogsdill J.R., and Reynolds P.R. 2013. Conditional overexpression of RAGE by embryonic alveolar epithelium compromises the respiratory
membrane and impairs endothelial cell differentiation. Respir Res 14(1):108.
Winden D.R., Barton D.B, Betteridge B.C, Bodine J.S, Jones C.M., Rogers
G.D., Chavarria M., Wright A.J., Jergensen Z.R., and Reynolds P.R. 2014. Antenatal
Exposure of Maternal Secondhand Smoke (SHS) Increases Fetal Lung Expression of
RAGE and Induces RAGE-Mediated Pulmonary Inflammation. In preparation.
Tippetts, Trevor S., Winden, Duane R., Swensen, Adam C., Thatcher, Mikayla
O., Saito, Rex X., Condie, Tyler X, Simmons, Kurtis X., Judd, Allan M., Prince, John
T., Reynolds, Paul R., Bikman, Benjamin T. 2014. Cigarette smoke increases
cardiomyocyte ceramide accumulation and disrupts mitochondrial function. Submitted.
Thatcher, Mikayla O., Tippetts, Trevor S., Nelson, Michael B., Swensen, Adam
C., Winden, Duane R., Anderson, Madeline C., Johnson, Ian E., Porter, James P.,
Prince, John T., Reynolds, Paul R., Bikman, Benjamin T. 2014. Ceramides mediate
cigarette smoke-induced metabolic disruption. Submitted.
Non-peer Reviewed Publications
Human Anatomy Guide Robert E. Seegmiller, David Busath and Duane Winden
Outernet Publishing LLC ©2009
Human Anatomy: Laboratory Manual 2nd Edition Duane Winden and Robert E.
Seegmiller Outernet Publishing LLC ©2009
Human Anatomy: Laboratory Manual 2nd Edition, Companion CD ROM Duane
Winden, Robert E. Seegmiller Outernet Publishing LLC ©2002
Human Anatomy: Laboratory Manual 1st Edition Duane Winden and Robert E.
Seegmiller Outernet Publishing LLC ©2001
Human Anatomy: Laboratory Manual 1st Edition, Companion CD ROM Duane
Winden and Robert E. Seegmiller Outernet Publishing LLC ©2001
Destinos: CD ROM Supplement McGraw-Hill ©1999
Teratology Training Guide Duane R Winden and Robert E Seegmiller Taras
Development Corporation ©1996
Developmental Toxicity of Carbazole and Benzo (a) carbazole in Mice Duane
Winden Brigham Young University 1994
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Abstracts

Nelson M.B., Tippetts T., Winden D.R., Reynolds P.R., and Bikman B. RAGE
activation reduces cardiomyocyte mitochondrial function in a ceramide-dependent
manner. ADA Meeting 2014.
Tippettes T., Winden D.R., Wagner M., Condie T., Reynolds P.R., and Bikman B.
2014. Ceramide is necessary for cigarette smoke-induced reduced heart mitochondrial
function. EB Meeting 2014.
Thatcher M., Tippetts T., Johnson I., Holub Z., Nelson M., Winden D.R.,
Reynolds P.R., and Bikman B. Ceramide mediates cigarette smoke-induced skeletal
muscle metabolic disruption. ADA Meeting 2014.
Wood T.T., Winden D.R., Barton D.B., Betteridge B.C., Marlor D.R., Wright
A.J., Jones C.M., Chavarria M., Rogers G.D., and Reynolds P.R. 2014. Targeted mice
reveal a role for RAGE in an early inflammatory response to tobacco smoke. FASEB J,
EB Meeting 2014
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